価格表

在庫・価格 : 2024年06月08日 18時37分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Flk-1/Fc Chimera, Human, Recombinant <Vascular Endothelial Cell Growth Factor Receptor 2/Fc Chimera> <KDR> <VEGF Receptor 2>
データシート
357-KD-050 RSDアールアンドディー システムス
R&D Systems, Inc.
50 μg ¥93,000
(未発注)
追加

在庫・価格 : 2024年06月08日 18時37分 現在

Flk-1/Fc Chimera, Human, Recombinant <Vascular Endothelial Cell Growth Factor Receptor 2/Fc Chimera> <KDR> <VEGF Receptor 2>

  • 商品コード:357-KD-050
  • メーカー:RSD
  • 包装:50μg
  • 価格: ¥93,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Saaristo A et al. Lymphangiogenic gene therapy with minimal blood vascular side effects. J. Exp. Med. 2002 Sep;196(6):719-30
Saaristo A et al
2002/01/01
Application: Binding Assay, Sample Type: Cell Lysates PubMed
2 Orecchia A et al. Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the alpha 5 beta 1 integrin. J. Cell. Sci. 2003 Sep;116(Pt 17):3479-89
Orecchia A et al
2003/01/01
Species: Human, Application: Bioassay, Sample type: Whole Cells PubMed
3 Seo KH et al. Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation. Cancer Res. 2004 Sep;64(18):6482-8
Seo KH et al
2004/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
4 Woolard J et al. VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res. 2004 Nov;64(21):7822-35
Woolard J et al
2004/01/01
Application: Receptor Binding Assay, Sample Type: recombiant VEGF165,recombinant VEGF165b PubMed
5 Oliner J et al. Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. Cancer Cell 2004 Nov;6(5):507-16
Oliner J et al
2004/01/01
Application: Functional ELISA PubMed
6 Ozawa T et al. Erythroid cells play essential roles in angiogenesis by bone marrow cell implantation. J. Mol. Cell. Cardiol. 2006 May;40(5):629-38
Ozawa T et al
2006/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
7 Getmanova EV et al. Antagonists to human and mouse vascular endothelial growth factor receptor 2 generated by directed protein evolution in vitro. Chem. Biol. 2006 May;13(5):549-56
Getmanova EV et al
2006/01/01
Species: Human, Application: Biacore binding study, Sample type: recombinant VEGF PubMed
8 Ren WP et al. Association between UHMWPE particle-induced inflammatory osteoclastogenesis and expression of RANKL, VEGF, and Flt-1 in vivo. Biomaterials 2006 Oct;27(30):5161-9
Ren WP et al
2006/01/01
Species: Mouse, Application: In Vivo, In Vivo PubMed
9 Lake AC et al. Low molecular weight fucoidan increases VEGF165-induced endothelial cell migration by enhancing VEGF165 binding to VEGFR-2 and NRP1. J. Biol. Chem. 2006 Dec;281(49):37844-52
Lake AC et al
2006/01/01
Application: Bioassay, Sample Type: Buffer PubMed
10 Backer MV et al. Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes. Nat. Med. 2007 Apr;13(4):504-9
Backer MV et al
2007/01/01
Species: Mouse, Application: In Vivo PubMed
11 Wirzenius M et al. Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. J. Exp. Med. 2007 Jun;204(6):1431-40
Wirzenius M et al
2007/01/01
Species: Porcine, Application: Bioassay, Sample type: Whole Cells PubMed
12 Pan Q et al. Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting. J. Biol. Chem. 2007 Aug;282(33):24049-56
Pan Q et al
2007/01/01
Species: Human, Application: Binding Assay, Sample type: recombinant VEGF PubMed
13 Krilleke D et al. Molecular mapping and functional characterization of the VEGF164 heparin-binding domain. J. Biol. Chem. 2007 Sep;282(38):28045-56
Krilleke D et al
2007/01/01
Application: Competitive Binding Assay PubMed
14 Gustafsdottir SM et al. Use of proximity ligation to screen for inhibitors of interactions between vascular endothelial growth factor A and its receptors. Clin. Chem. 2008 Jul;54(7):1218-25
Gustafsdottir SM et al
2008/01/01
Application: Bioassay PubMed
15 Ponticelli S et al. Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1. J. Biol. Chem. 2008 Dec;283(49):34250-9
Ponticelli S et al
2008/01/01
Application: Bioassay, Sample Type: Other: Tetrameric 4-23-5 Peptide PubMed
16 Rennel ES et al. VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo. Br. J. Cancer 2009 Oct;101(7):1183-93
Rennel ES et al
2009/01/01
Application: Bioassay, Sample Type: protein in buffer PubMed
17 Brookes K et al. Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs. Br. J. Cancer 2010 May;102(10):1524-32
Brookes K et al
2010/01/01
Application: Other: See notes, Sample Type: Plasma (EDTA) PubMed
18 Lorquet S et al. Soluble forms of VEGF receptor-1 and -2 promote vascular maturation via mural cell recruitment. FASEB J. 2010 Oct;24(10):3782-95
Lorquet S et al
2010/01/01
Application: Bioassay,IHC Fresh, Sample Type: Whole Cells PubMed
19 Nishiguchi KM et al. Regulation of pathologic retinal angiogenesis in mice and inhibition of VEGF-VEGFR2 binding by soluble heparan sulfate. PLoS ONE 2010;5(10):e13493
Nishiguchi KM et al
2010/01/01
Application: Bioassay, Sample Type: ocular fluid PubMed
20 Goyal A et al. Endorepellin, the angiostatic module of perlecan, interacts with both the ?2?1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonism. J. Biol. Chem. 2011 Jul;286(29):25947-62
Goyal A et al
2011/01/01
Application: Binding Competition, Sample Type: recombinant VEGFA and Endorepellin PubMed
21 Lorenzon E et al. MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway. Oncogene 2012 Jun;31(26):3136-47
Lorenzon E et al
2012/01/01
Application: Surface Plasmon Resonance, Sample Type: recombinanat VEGF165 PubMed
22 Pfister C et al. Vascular endothelial growth factor signals through platelet-derived growth factor receptor &#x3B2; in meningiomas in vitro. Br. J. Cancer 2012 Nov;107(10):1702-13
Pfister C et al
2012/01/01
Application: TaqMan Protein Assay Control, Sample Type: N/A PubMed
23 Harris NC et al. The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology. J. Biol. Chem. 2013 Mar;288(12):8176-86
Harris NC et al
2013/01/01
Application: Biosensor Analysis, Sample Type: peptides PubMed
24 Qi JH et al. Tissue inhibitor of metalloproteinases-3 peptides inhibit angiogenesis and choroidal neovascularization in mice. PLoS ONE 2013;8(3):e55667
Qi JH et al
2013/01/01
Application: Competitive ELISA, Sample Type: protein PubMed
25 Maertens L et al. Bone marrow-derived mesenchymal stem cells drive lymphangiogenesis. PLoS ONE 2014;9(9):e106976
Maertens L et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
26 Kuchroo P et al. Paracrine factors secreted by umbilical cord-derived mesenchymal stem cells induce angiogenesis in vitro by a VEGF-independent pathway. Stem Cells Dev. 2015 Feb;24(4):437-50
Kuchroo P et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
27 Fleetwood F et al. Simultaneous targeting of two ligand-binding sites on VEGFR2 using biparatopic Affibody molecules results in dramatically improved affinity. Sci Rep 2014;4:7518
Fleetwood F et al
2014/01/01
Application: Bioassay, Sample Type: affibody molecule PubMed
28 Teran M et al. Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity. J. Biol. Chem. 2015 Jun;290(26):16451-62
Teran M et al
2015/01/01
Application: Bioassay, Sample Type: protein PubMed
  • No.: 1
  • 文献情報:
    Saaristo A et al. Lymphangiogenic gene therapy with minimal blood vascular side effects. J. Exp. Med. 2002 Sep;196(6):719-30
    Saaristo A et al
    2002/01/01
  • 備考:
    Application: Binding Assay, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Orecchia A et al. Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the alpha 5 beta 1 integrin. J. Cell. Sci. 2003 Sep;116(Pt 17):3479-89
    Orecchia A et al
    2003/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Seo KH et al. Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation. Cancer Res. 2004 Sep;64(18):6482-8
    Seo KH et al
    2004/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Woolard J et al. VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res. 2004 Nov;64(21):7822-35
    Woolard J et al
    2004/01/01
  • 備考:
    Application: Receptor Binding Assay, Sample Type: recombiant VEGF165,recombinant VEGF165b
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Oliner J et al. Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. Cancer Cell 2004 Nov;6(5):507-16
    Oliner J et al
    2004/01/01
  • 備考:
    Application: Functional ELISA
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Ozawa T et al. Erythroid cells play essential roles in angiogenesis by bone marrow cell implantation. J. Mol. Cell. Cardiol. 2006 May;40(5):629-38
    Ozawa T et al
    2006/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Getmanova EV et al. Antagonists to human and mouse vascular endothelial growth factor receptor 2 generated by directed protein evolution in vitro. Chem. Biol. 2006 May;13(5):549-56
    Getmanova EV et al
    2006/01/01
  • 備考:
    Species: Human, Application: Biacore binding study, Sample type: recombinant VEGF
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Ren WP et al. Association between UHMWPE particle-induced inflammatory osteoclastogenesis and expression of RANKL, VEGF, and Flt-1 in vivo. Biomaterials 2006 Oct;27(30):5161-9
    Ren WP et al
    2006/01/01
  • 備考:
    Species: Mouse, Application: In Vivo, In Vivo
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Lake AC et al. Low molecular weight fucoidan increases VEGF165-induced endothelial cell migration by enhancing VEGF165 binding to VEGFR-2 and NRP1. J. Biol. Chem. 2006 Dec;281(49):37844-52
    Lake AC et al
    2006/01/01
  • 備考:
    Application: Bioassay, Sample Type: Buffer
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Backer MV et al. Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes. Nat. Med. 2007 Apr;13(4):504-9
    Backer MV et al
    2007/01/01
  • 備考:
    Species: Mouse, Application: In Vivo
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Wirzenius M et al. Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. J. Exp. Med. 2007 Jun;204(6):1431-40
    Wirzenius M et al
    2007/01/01
  • 備考:
    Species: Porcine, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Pan Q et al. Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting. J. Biol. Chem. 2007 Aug;282(33):24049-56
    Pan Q et al
    2007/01/01
  • 備考:
    Species: Human, Application: Binding Assay, Sample type: recombinant VEGF
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Krilleke D et al. Molecular mapping and functional characterization of the VEGF164 heparin-binding domain. J. Biol. Chem. 2007 Sep;282(38):28045-56
    Krilleke D et al
    2007/01/01
  • 備考:
    Application: Competitive Binding Assay
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Gustafsdottir SM et al. Use of proximity ligation to screen for inhibitors of interactions between vascular endothelial growth factor A and its receptors. Clin. Chem. 2008 Jul;54(7):1218-25
    Gustafsdottir SM et al
    2008/01/01
  • 備考:
    Application: Bioassay
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Ponticelli S et al. Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1. J. Biol. Chem. 2008 Dec;283(49):34250-9
    Ponticelli S et al
    2008/01/01
  • 備考:
    Application: Bioassay, Sample Type: Other: Tetrameric 4-23-5 Peptide
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Rennel ES et al. VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo. Br. J. Cancer 2009 Oct;101(7):1183-93
    Rennel ES et al
    2009/01/01
  • 備考:
    Application: Bioassay, Sample Type: protein in buffer
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Brookes K et al. Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs. Br. J. Cancer 2010 May;102(10):1524-32
    Brookes K et al
    2010/01/01
  • 備考:
    Application: Other: See notes, Sample Type: Plasma (EDTA)
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Lorquet S et al. Soluble forms of VEGF receptor-1 and -2 promote vascular maturation via mural cell recruitment. FASEB J. 2010 Oct;24(10):3782-95
    Lorquet S et al
    2010/01/01
  • 備考:
    Application: Bioassay,IHC Fresh, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Nishiguchi KM et al. Regulation of pathologic retinal angiogenesis in mice and inhibition of VEGF-VEGFR2 binding by soluble heparan sulfate. PLoS ONE 2010;5(10):e13493
    Nishiguchi KM et al
    2010/01/01
  • 備考:
    Application: Bioassay, Sample Type: ocular fluid
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Goyal A et al. Endorepellin, the angiostatic module of perlecan, interacts with both the ?2?1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonism. J. Biol. Chem. 2011 Jul;286(29):25947-62
    Goyal A et al
    2011/01/01
  • 備考:
    Application: Binding Competition, Sample Type: recombinant VEGFA and Endorepellin
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Lorenzon E et al. MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway. Oncogene 2012 Jun;31(26):3136-47
    Lorenzon E et al
    2012/01/01
  • 備考:
    Application: Surface Plasmon Resonance, Sample Type: recombinanat VEGF165
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Pfister C et al. Vascular endothelial growth factor signals through platelet-derived growth factor receptor &#x3B2; in meningiomas in vitro. Br. J. Cancer 2012 Nov;107(10):1702-13
    Pfister C et al
    2012/01/01
  • 備考:
    Application: TaqMan Protein Assay Control, Sample Type: N/A
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Harris NC et al. The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology. J. Biol. Chem. 2013 Mar;288(12):8176-86
    Harris NC et al
    2013/01/01
  • 備考:
    Application: Biosensor Analysis, Sample Type: peptides
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Qi JH et al. Tissue inhibitor of metalloproteinases-3 peptides inhibit angiogenesis and choroidal neovascularization in mice. PLoS ONE 2013;8(3):e55667
    Qi JH et al
    2013/01/01
  • 備考:
    Application: Competitive ELISA, Sample Type: protein
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Maertens L et al. Bone marrow-derived mesenchymal stem cells drive lymphangiogenesis. PLoS ONE 2014;9(9):e106976
    Maertens L et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Kuchroo P et al. Paracrine factors secreted by umbilical cord-derived mesenchymal stem cells induce angiogenesis in vitro by a VEGF-independent pathway. Stem Cells Dev. 2015 Feb;24(4):437-50
    Kuchroo P et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Fleetwood F et al. Simultaneous targeting of two ligand-binding sites on VEGFR2 using biparatopic Affibody molecules results in dramatically improved affinity. Sci Rep 2014;4:7518
    Fleetwood F et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: affibody molecule
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Teran M et al. Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity. J. Biol. Chem. 2015 Jun;290(26):16451-62
    Teran M et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: protein
  • 参照:
    PubMed